Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.
- DOI
- 10.1002/cpt.70378
- Published
- 2026 Oct
- Container
- Clinical pharmacology and therapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cpt.70378,
title = {Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.},
author = {Kostiou V and Chelliah V and van der Graaf PH and Kierzek AM and Farzana T and Mailankody S and Jurgens EM},
year = {2026},
journal = {Clinical pharmacology and therapeutics},
doi = {10.1002/cpt.70378},
url = {https://doi.org/10.1002/cpt.70378}
}RIS
TY - JOUR TI - Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data. AU - Kostiou V AU - Chelliah V AU - van der Graaf PH AU - Kierzek AM AU - Farzana T AU - Mailankody S AU - Jurgens EM PY - 2026 JO - Clinical pharmacology and therapeutics DO - 10.1002/cpt.70378 UR - https://doi.org/10.1002/cpt.70378 ER -
APA
V, K., V, C., PH, V. D. G., AM, K., T, F., S, M., & EM, J. (2026). Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.70378
Source records
- pubmed · retrieved 2026-09-26T17:27:42.947Z